Leading experts explore the pragmatic application of the tools of genomic and molecular biology research to the treatment of stroke. Providing the reader with cutting-edge reviews of clinical and preclinical genomics, the authors relate changes in gene expression to physiological endpoints-such as functional imaging paradigms-to produce a more holistic approach in which molecular biology goes hand-in-hand with stroke pathophysiology. Topics of special interest include stem cell transplantation, gene therapy, clinical gene/gene interaction studies, and cytokine drug discovery.To calculate the mean T2 in this ROI, click on the ROI min/mean and max button in the ROI panel on the left-hand side. ... In our experience, the maximal percentage weight loss is a very reliable indicator of the severity of the lesion, as indicated by the ... Of the publications using o.p. delivery in the Lewis rat, there seems to be a large variation in dose between groups to achieve similar lesion damage.
|Author||:||Simon J. Read, David Virley|
|Publisher||:||Springer Science & Business Media - 2005-01-01|